Selected research
Market Analysis & Forecast
Global Swine Circovirus Vaccine Market Analysis and Forecast 2026-2032
Market perspective
The global Swine Circovirus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Swine Circovirus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Swine Circovirus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Swine Circovirus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Swine Circovirus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Swine Circovirus Vaccine include Boehringer Ingelheim, CAVAC, Chopper Biology, DHN, Komipharm, Ringpu Biology, Zoetis, ChengDu Tecbond and Jinyu Bio-Technology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Swine Circovirus Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Swine Circovirus Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Swine Circovirus Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Swine Circovirus Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Swine Circovirus Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Swine Circovirus Vaccine sales, projected growth trends, production technology, application and end-user industry.
Swine Circovirus Vaccine Segment by Company
Boehringer Ingelheim
CAVAC
Chopper Biology
DHN
Komipharm
Ringpu Biology
Zoetis
ChengDu Tecbond
Jinyu Bio-Technology
Qilu Animal
Swine Circovirus Vaccine Segment by Type
Genetic Engineering Vaccine
Killed Vaccines
Swine Circovirus Vaccine Segment by Application
Piglets
Adults Pigs
Swine Circovirus Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Circovirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Circovirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Circovirus Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Swine Circovirus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Swine Circovirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Circovirus Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Genetic Engineering Vaccine
- Killed Vaccines
Applications
- Piglets
- Adults Pigs
Companies covered
- Boehringer Ingelheim
- CAVAC
- Chopper Biology
- DHN
- Komipharm
- Ringpu Biology
- Zoetis
- ChengDu Tecbond
- Jinyu Bio-Technology
- Qilu Animal
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Swine Circovirus Vaccine Market by Type
- 1.2.1 Global Swine Circovirus Vaccine Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Genetic Engineering Vaccine
- 1.2.3 Killed Vaccines
- 1.3 Swine Circovirus Vaccine Market by Application
- 1.3.1 Global Swine Circovirus Vaccine Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Piglets
- 1.3.3 Adults Pigs
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Swine Circovirus Vaccine Market Dynamics
- 2.1 Swine Circovirus Vaccine Industry Trends
- 2.2 Swine Circovirus Vaccine Industry Drivers
- 2.3 Swine Circovirus Vaccine Industry Opportunities and Challenges
- 2.4 Swine Circovirus Vaccine Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Swine Circovirus Vaccine Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Swine Circovirus Vaccine Revenue by Region
- 3.2.1 Global Swine Circovirus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Swine Circovirus Vaccine Revenue by Region (2021-2026)
- 3.2.3 Global Swine Circovirus Vaccine Revenue by Region (2027-2032)
- 3.2.4 Global Swine Circovirus Vaccine Revenue Market Share by Region (2021-2032)
- 3.3 Global Swine Circovirus Vaccine Sales Estimates and Forecasts 2021-2032
- 3.4 Global Swine Circovirus Vaccine Sales by Region
- 3.4.1 Global Swine Circovirus Vaccine Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Swine Circovirus Vaccine Sales by Region (2021-2026)
- 3.4.3 Global Swine Circovirus Vaccine Sales by Region (2027-2032)
- 3.4.4 Global Swine Circovirus Vaccine Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Swine Circovirus Vaccine Revenue by Manufacturers
- 4.1.1 Global Swine Circovirus Vaccine Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Swine Circovirus Vaccine Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Swine Circovirus Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Swine Circovirus Vaccine Sales by Manufacturers
- 4.2.1 Global Swine Circovirus Vaccine Sales by Manufacturers (2021-2026)
- 4.2.2 Global Swine Circovirus Vaccine Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Swine Circovirus Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Swine Circovirus Vaccine Sales Price by Manufacturers (2021-2026)
- 4.4 Global Swine Circovirus Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Swine Circovirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Swine Circovirus Vaccine Manufacturers, Product Type & Application
- 4.7 Global Swine Circovirus Vaccine Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Swine Circovirus Vaccine Market CR5 and HHI
- 4.8.2 2025 Swine Circovirus Vaccine Tier 1, Tier 2, and Tier 3
5 Swine Circovirus Vaccine Market by Type
- 5.1 Global Swine Circovirus Vaccine Revenue by Type
- 5.1.1 Global Swine Circovirus Vaccine Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Swine Circovirus Vaccine Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Swine Circovirus Vaccine Revenue Market Share by Type (2021-2032)
- 5.2 Global Swine Circovirus Vaccine Sales by Type
- 5.2.1 Global Swine Circovirus Vaccine Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Swine Circovirus Vaccine Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Swine Circovirus Vaccine Sales Market Share by Type (2021-2032)
- 5.3 Global Swine Circovirus Vaccine Price by Type
6 Swine Circovirus Vaccine Market by Application
- 6.1 Global Swine Circovirus Vaccine Revenue by Application
- 6.1.1 Global Swine Circovirus Vaccine Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Swine Circovirus Vaccine Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Swine Circovirus Vaccine Revenue Market Share by Application (2021-2032)
- 6.2 Global Swine Circovirus Vaccine Sales by Application
- 6.2.1 Global Swine Circovirus Vaccine Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Swine Circovirus Vaccine Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Swine Circovirus Vaccine Sales Market Share by Application (2021-2032)
- 6.3 Global Swine Circovirus Vaccine Price by Application
7 Company Profiles
- 7.1 Boehringer Ingelheim
- 7.1.1 Boehringer Ingelheim Company Information
- 7.1.2 Boehringer Ingelheim Business Overview
- 7.1.3 Boehringer Ingelheim Swine Circovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Boehringer Ingelheim Swine Circovirus Vaccine Product Portfolio
- 7.1.5 Boehringer Ingelheim Recent Developments
- 7.2 CAVAC
- 7.2.1 CAVAC Company Information
- 7.2.2 CAVAC Business Overview
- 7.2.3 CAVAC Swine Circovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 CAVAC Swine Circovirus Vaccine Product Portfolio
- 7.2.5 CAVAC Recent Developments
- 7.3 Chopper Biology
- 7.3.1 Chopper Biology Company Information
- 7.3.2 Chopper Biology Business Overview
- 7.3.3 Chopper Biology Swine Circovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Chopper Biology Swine Circovirus Vaccine Product Portfolio
- 7.3.5 Chopper Biology Recent Developments
- 7.4 DHN
- 7.4.1 DHN Company Information
- 7.4.2 DHN Business Overview
- 7.4.3 DHN Swine Circovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 DHN Swine Circovirus Vaccine Product Portfolio
- 7.4.5 DHN Recent Developments
- 7.5 Komipharm
- 7.5.1 Komipharm Company Information
- 7.5.2 Komipharm Business Overview
- 7.5.3 Komipharm Swine Circovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Komipharm Swine Circovirus Vaccine Product Portfolio
- 7.5.5 Komipharm Recent Developments
- 7.6 Ringpu Biology
- 7.6.1 Ringpu Biology Company Information
- 7.6.2 Ringpu Biology Business Overview
- 7.6.3 Ringpu Biology Swine Circovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Ringpu Biology Swine Circovirus Vaccine Product Portfolio
- 7.6.5 Ringpu Biology Recent Developments
- 7.7 Zoetis
- 7.7.1 Zoetis Company Information
- 7.7.2 Zoetis Business Overview
- 7.7.3 Zoetis Swine Circovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Zoetis Swine Circovirus Vaccine Product Portfolio
- 7.7.5 Zoetis Recent Developments
- 7.8 ChengDu Tecbond
- 7.8.1 ChengDu Tecbond Company Information
- 7.8.2 ChengDu Tecbond Business Overview
- 7.8.3 ChengDu Tecbond Swine Circovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 ChengDu Tecbond Swine Circovirus Vaccine Product Portfolio
- 7.8.5 ChengDu Tecbond Recent Developments
- 7.9 Jinyu Bio-Technology
- 7.9.1 Jinyu Bio-Technology Company Information
- 7.9.2 Jinyu Bio-Technology Business Overview
- 7.9.3 Jinyu Bio-Technology Swine Circovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Jinyu Bio-Technology Swine Circovirus Vaccine Product Portfolio
- 7.9.5 Jinyu Bio-Technology Recent Developments
- 7.10 Qilu Animal
- 7.10.1 Qilu Animal Company Information
- 7.10.2 Qilu Animal Business Overview
- 7.10.3 Qilu Animal Swine Circovirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Qilu Animal Swine Circovirus Vaccine Product Portfolio
- 7.10.5 Qilu Animal Recent Developments
8 North America
- 8.1 North America Swine Circovirus Vaccine Market Size by Type
- 8.1.1 North America Swine Circovirus Vaccine Revenue by Type (2021-2032)
- 8.1.2 North America Swine Circovirus Vaccine Sales by Type (2021-2032)
- 8.1.3 North America Swine Circovirus Vaccine Price by Type (2021-2032)
- 8.2 North America Swine Circovirus Vaccine Market Size by Application
- 8.2.1 North America Swine Circovirus Vaccine Revenue by Application (2021-2032)
- 8.2.2 North America Swine Circovirus Vaccine Sales by Application (2021-2032)
- 8.2.3 North America Swine Circovirus Vaccine Price by Application (2021-2032)
- 8.3 North America Swine Circovirus Vaccine Market Size by Country
- 8.3.1 North America Swine Circovirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Swine Circovirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Swine Circovirus Vaccine Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Swine Circovirus Vaccine Market Size by Type
- 9.1.1 Europe Swine Circovirus Vaccine Revenue by Type (2021-2032)
- 9.1.2 Europe Swine Circovirus Vaccine Sales by Type (2021-2032)
- 9.1.3 Europe Swine Circovirus Vaccine Price by Type (2021-2032)
- 9.2 Europe Swine Circovirus Vaccine Market Size by Application
- 9.2.1 Europe Swine Circovirus Vaccine Revenue by Application (2021-2032)
- 9.2.2 Europe Swine Circovirus Vaccine Sales by Application (2021-2032)
- 9.2.3 Europe Swine Circovirus Vaccine Price by Application (2021-2032)
- 9.3 Europe Swine Circovirus Vaccine Market Size by Country
- 9.3.1 Europe Swine Circovirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Swine Circovirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Swine Circovirus Vaccine Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Swine Circovirus Vaccine Market Size by Type
- 10.1.1 China Swine Circovirus Vaccine Revenue by Type (2021-2032)
- 10.1.2 China Swine Circovirus Vaccine Sales by Type (2021-2032)
- 10.1.3 China Swine Circovirus Vaccine Price by Type (2021-2032)
- 10.2 China Swine Circovirus Vaccine Market Size by Application
- 10.2.1 China Swine Circovirus Vaccine Revenue by Application (2021-2032)
- 10.2.2 China Swine Circovirus Vaccine Sales by Application (2021-2032)
- 10.2.3 China Swine Circovirus Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Swine Circovirus Vaccine Market Size by Type
- 11.1.1 Asia Swine Circovirus Vaccine Revenue by Type (2021-2032)
- 11.1.2 Asia Swine Circovirus Vaccine Sales by Type (2021-2032)
- 11.1.3 Asia Swine Circovirus Vaccine Price by Type (2021-2032)
- 11.2 Asia Swine Circovirus Vaccine Market Size by Application
- 11.2.1 Asia Swine Circovirus Vaccine Revenue by Application (2021-2032)
- 11.2.2 Asia Swine Circovirus Vaccine Sales by Application (2021-2032)
- 11.2.3 Asia Swine Circovirus Vaccine Price by Application (2021-2032)
- 11.3 Asia Swine Circovirus Vaccine Market Size by Country
- 11.3.1 Asia Swine Circovirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Swine Circovirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Swine Circovirus Vaccine Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Swine Circovirus Vaccine Market Size by Type
- 12.1.1 SAMEA Swine Circovirus Vaccine Revenue by Type (2021-2032)
- 12.1.2 SAMEA Swine Circovirus Vaccine Sales by Type (2021-2032)
- 12.1.3 SAMEA Swine Circovirus Vaccine Price by Type (2021-2032)
- 12.2 SAMEA Swine Circovirus Vaccine Market Size by Application
- 12.2.1 SAMEA Swine Circovirus Vaccine Revenue by Application (2021-2032)
- 12.2.2 SAMEA Swine Circovirus Vaccine Sales by Application (2021-2032)
- 12.2.3 SAMEA Swine Circovirus Vaccine Price by Application (2021-2032)
- 12.3 SAMEA Swine Circovirus Vaccine Market Size by Country
- 12.3.1 SAMEA Swine Circovirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Swine Circovirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Swine Circovirus Vaccine Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Swine Circovirus Vaccine Value Chain Analysis
- 13.1.1 Swine Circovirus Vaccine Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Swine Circovirus Vaccine Production Mode & Process
- 13.2 Swine Circovirus Vaccine Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Swine Circovirus Vaccine Distributors
- 13.2.3 Swine Circovirus Vaccine Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst